Real value

I was reviewing some of the recent price targets placed on BNO with one eye on the current (relatively stable) SP and the exercise price on the options issued recently. I don't want to undersell BNO because I think it is great value today but the targets all seem to align pretty well (perhaps that is a coincidence) and point to a mkt cap of $250m+ (from the current ~$150m after taking the cash out). Doesn't sound too bad given the up side IMO is likely to be well north of $250m with another positive clinical trial result. It was then pointed out to me that to develop a pipeline of products like BNOs would cost a lot more than $250m. DYOR but it is food for thought. GLTA